Symmetrel is an antiviral medication used primarily for the prevention of influenza a infection. It contains the active ingredient amantadine which works by inhibiting the replication of viral particles. The drug blocks the function of the viral m2 ion channel which is essential for uncoating of the virus inside host cells. By preventing uncoating the medication reduces the spread of infected cells and supports the body's immune response. This mechanism leads to lower viral load and shorter duration of symptoms when administered early. The physiological process most affected is the viral entry and spread within respiratory epithelial tissues.

Symmetrel is an antiviral medication that was originally introduced for the prevention and treatment of influenza a virus infections. Its pharmacological action consists of interfering with the replication cycle of certain enveloped viruses, particularly influenza a and some strains of influenza b. The drug works by blocking the uncoating of the viral envelope after the virus enters a host cell, which prevents the release of viral rna into the cytoplasm. This blockade disrupts the viral matrix protein function and impairs the assembly of new virions, thereby reducing the spread of infection within the respiratory tract. Clinically, it is used to lessen the severity and duration of flu symptoms when administered early in the course of illness. At the cellular level, the inhibition of viral uncoating limits the ability of the virus to initiate replication, leading to a decrease in viral protein synthesis and particle formation. The overall therapeutic effect is achieved through this specific interference with the early stages of viral entry and replication, offering modest benefit in otherwise healthy individuals infected with susceptible strains.

Symmetrel may cause dizziness and headache in some users. Skin reactions such as rash or itching can occur. Some individuals experience nausea or loss of appetite. Central nervous system effects like insomnia or agitation are reported. Rarely, visual disturbances such as blurred vision may appear. Overall these reactions are generally mild and transient but can vary among patients.

Symmetrel can cause dizziness and headache in some users. It may also lead to trouble sleeping or vivid dreams. Some people experience dry mouth or loss of appetite. Nausea and constipation are possible gastrointestinal effects. The medication can rarely cause visual disturbances such as blurred vision. The medication can rarely cause swelling in the ankles or feet. Most side effects are mild and improve with continued use.